Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary

• Main Authors: Yicong Liang, MD (Author), Faith A.P. Zeng (Author), Tabrez Sheriff, MD (Author), Anna Wilson, MD (Author), Asli Bilgic, MD (Author), Grant Feng (Author), John H. Stone, MD, MPH (Author), Dedee F. Murrell, MA, BMBCh, MD (Author)
• Format: Book
• Published: Elsevier, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs). The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based glucocorticoid-induced adverse effects monitoring instrument. Objective: To investigate whether the GTI score was able to accurately...